4.7 Article

The triterpene, methyl-3β-hydroxylanosta-9,24-dien-21-oate (RA3), attenuates high glucose-induced oxidative damage and apoptosis by improving energy metabolism

Journal

PHYTOMEDICINE
Volume 85, Issue -, Pages -

Publisher

ELSEVIER GMBH
DOI: 10.1016/j.phymed.2021.153546

Keywords

Hyperglycemia; Triterpene; Oxidative stress; Diabetic cardiomyopathy; Apoptosis

Funding

  1. South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the Internship Scholarship Programme
  2. Research Strengthening and Capacity Development Funding Opportunity for Selected Universities Initiative [PC 57009]
  3. SAMRC
  4. Biomedical Research and Innovation Platform
  5. SAMRCs Intra-Mural Postdoctoral Fellowship Programme - South African National Treasury
  6. National Research Foundation [UID120812]

Ask authors/readers for more resources

The study demonstrates that RA3 can alleviate hyperglycemia-induced cardiac damage through various mechanisms, including improving glucose uptake, reducing oxidative stress and antioxidant enzyme activity, decreasing intracellular lipid content, and mitigating cell apoptosis.
Background: Hyperglycemia-induced cardiovascular dysfunction has been linked to oxidative stress and accelerated apoptosis in the diabetic myocardium. While there is currently no treatment for diabetic cardiomyopathy (DCM), studies suggest that the combinational use of anti-hyperglycemic agents and triterpenes could be effective in alleviating DCM. Hypothesis: To investigate the therapeutic effect of methyl-3 ss-hydroxylanosta-9,24-dien-21-oate (RA3), in the absence or presence of the anti-diabetic drug, metformin (MET), against hyperglycemia-induced cardiac injury using an in vitro H9c2 cell model. Methods: To mimic a hyperglycemic state, H9c2 cells were exposed to high glucose (HG, 33 mM) for 24 h. Thereafter, the cells were treated with RA3 (1 mu M), MET (1 mu M) and the combination of MET (1 mu M) plus RA3 (1 mu M) for 24 h, to assess the treatments therapeutic effect. Results: Biochemical analysis revealed that RA3, with or without MET, improves glucose uptake via insulindependent (IRS-1/PI3K/Akt signaling) and independent (AMPK) pathways whilst ameliorating the activity of antioxidant enzymes in the H9c2 cells. Mechanistically, RA3 was able to alleviate HG-stimulated oxidative stress through the inhibition of reactive oxygen species (ROS) and lipid peroxidation as well as the reduced expression of the PKC/NF-kappa B cascade through decreased intracellular lipid content. Subsequently, RA3 was able to mitigate HG-induced apoptosis by decreasing the activity of caspase 3/7 and DNA fragmentation in the cardiomyoblasts. Conclusion: RA3, in the absence or presence of MET, demonstrated potent therapeutic properties against hyperglycemia-mediated cardiac damage and could be a suitable candidate in the prevention of DCM.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available